Assays
Collection Devices
Digital Cytology
Molecular Diagnostics
Screening Technologies
Hologic

Direct Load Tube Collection Kit

Transform Specimen Processing for COVID Testing

No uncapping and no specimen transfer. Expedite your SARS-CoV-2* workflow with a collection device that loads directly on the Panther® system. The Direct Load Tube Collection Kit is authorized for use with the Aptima® SARS-CoV-2 and Aptima SARS-CoV-2/Flu assays.
Hologic

Genius™ Digital Diagnostics System

Hologic introduces the Genius Digital Diagnostics System*

Genius Digital Diagnostics is the first CE-marked digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced volumetric imaging technology to help cytotechnologists and pathologists identify pre-cancerous lesions and cancer cells in women. The system can rapidly analyze all cells on a ThinPrep® Pap test digital image, narrowing tens of thousands of cells down to an AI-generated gallery of the most diagnostically relevant images. This will help provide healthcare providers with the critical information they need to guide earlier detection and better treatment decisions for the patients they serve.
Hologic

Hologic SARS-CoV-2 Assays

The emergence of SARS-CoV-2 was unforeseen, and the worldwide outbreak of COVID-19 has already impacted millions Since then, the need and recommendations for testing for SARS-CoV-2 have continuously evolved, requiring labs to be flexible with their strategies over time. Hologic’s SARS-CoV-2 portfolio and scalable automation enable labs to react to these changing needs and fully automate COVID-19 testing. With Panther® Scalable Solutions, you can run over 1000 tests in 24 hours, attaining first results in about 3 hours.1† The Panther Fusion® SARS-CoV-2 assay is a real-time PCR test and the Aptima® SARS-CoV-2 assay utilizes our proprietary TMA® technology. Both assays are intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens (Panther Fusion assay only) obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria.2,3 These assays are also intended for upper respiratory tract swab samples from individuals without symptoms or other reasons to suspect COVID-19 infection. The Aptima SARS-CoV-2/Flu assay utilizes our proprietary real-time TMA chemistry to detect and differentiate SARS-CoV-2, influenza A and influenza B from nasopharyngeal and nasal swabs obtained from individuals with signs and symptoms of a respiratory tract infection or who meet COVID-19 clinical and/or epidemiological criteria.4
Hologic

Hologic Transplant Assay

Give patients a better chance at life with our Transplant Portfolio of quantitative tests for the quantification of post-transplant infections.  

CMV and Viral Load Monitoring

Cytomegalovirus (CMV) infection is a common complication that affects organ transplant patients. CMV, a member of the herpes virus family, establishes a lifelong latent infection that is generally asymptomatic. However, in immunocompromised patients, such as transplant recipients, reactivation of latent CMV is often life-threatening. Guidelines recommend regular monitoring of CMV viral load as an aid for diagnosis of CMV infections and monitoring response to treatment.1, 2
Hologic

Panther Fusion® Open Access™

Laboratory Developed Tests (LDTs) are an essential part of diagnostics. Patients with certain medical conditions depend on these in-house developed tests when other options are not available. Save time and increase efficiency by consolidating your LDTs and IVD assays on the fully automated, sample-to-result, Panther Fusion system using the Open Access™ functionality.
Hologic

Panther Fusion® Respiratory Assays

The Panther Fusion Respiratory assays are the premier set of assays on the Panther Fusion system. You can provide truly personalized syndromic respiratory testing with qualitative detection and differentiation of the most common respiratory viruses from a single patient sample. Each Panther Fusion Respiratory assay can be processed independently or simultaneously with other Panther Fusion and Aptima® assays.
The Panther Fusion Flu A/B/RSV, Panther Fusion Paraflu and Panther Fusion AdV/hMPV/RV assays comprise the IVD respiratory testing menu on the fully automated Panther Fusion system. Each is a multiplex, real-time PCR in vitro diagnostic test. These assays can be run on nasopharyngeal (NP) swab specimens obtained from individuals exhibiting signs and symptoms of a respiratory tract infection.1-3  Additionally, the Panther Fusion SARS-CoV-2 assay has received Emergency Use Authorization for the detection of SARS-CoV-2 from nasopharyngeal, nasal, mid-turbinate and oropharyngeal swab specimens, nasopharyngeal wash/aspirate or nasal wash, and lower respiratory tract specimens.4
Hologic

Panther® Scalable Solutions

Panther Scalable Solutions allows you to expand your testing menu while adding on flexibility, capacity and walkaway time.
Hologic

Perinatal

The Healthcare Benefits of fFN Testing

  • Timely and appropriate interventions, such as antenatal steroids and magnesium sulfate.
  • Avoidance of unnecessary hospitalizations. One study showed that the average length of stay for patients with symptoms of preterm labor was reduced from 5.2 days to just 0.6 days after fFN testing was adopted.3
  • Effective transfer of patients at high risk of imminent preterm birth to a hospital with an appropriate NICU.

Interpreting Results

Negative Result2

 
  • Approximately 80% of patients will get a negative result.
  • A negative result means that patients have a less than 1% chance of giving birth in the next two weeks.
  • A negative result can help avoid unnecessary drug treatments, bed rest and hospitalizations. This knowledge can also provide peace of mind, freeing patients to continue with current activities without unnecessarily cancelling or rescheduling plans.
  • The Rapid fFN test can be repeated as often as every 2 weeks to monitor ongoing risk.

Positive Result2

 
  • Approximately 20% of patients will get a positive result
  • A positive result means the body is "leaking" fetal fibronectin, a sign that the patient may be preparing to give birth.
  • A positive result does not necessarily mean the patient will deliver soon, but it will alert the doctor to the fact that they are at higher risk for preterm labor.
  • The Rapid fFN test can be repeated as often as every 2 weeks to monitor ongoing risk.
Hologic

ThinPrep® 5000 Autoloader

Maximize Laboratory Efficiency with Fully Automated, Hands-Free Technology

Hologic

ThinPrep® 5000 Processor

Fully Automated so You Can Accomplish More Than Ever Before

Hologic

ThinPrep® Genesis™ Processor

Enabling Cytology Labs to Do More Offering automated chain of custody, streamlined cytology processing, and hands-free sample aliquoting in a single instrument, the ThinPrep Genesis processor promotes confidence in results while optimizing lab performance.
Hologic

ThinPrep® Processors

Meeting the Demands of Your Lab

ThinPrep processors are intuitive, versatile, and scalable solutions for laboratories of all volumes. The portfolio offers reliable, best-in-class systems that help cytology labs automate their processes – decreasing the need for hands-on labor and increasing laboratory efficiencies. And because every sample is a patient, our automated chain-of-custody technology delivers confidence in results without sacrificing productivity.
Loading...

Categories

Anesthesia
Cardiology
Catheters
Critical Care
Data Management
Dental
Gynaecology
Imaging
Inhaler
Lab Technologies
Nebuliser
Neonatal Care
Operation Theatre
Radiology
Surgical Imaging
Women's Health

Brands

Brands
Address: Bhive Workspace, Shri Krishna Temple Road, Indiranagar, Bangalore 560038

Phone: +91 888 454 4755

Email: support@infomeditech.com

Quick Links

Infomeditech © 2023 All Right Reserved